|Year : 2014 | Volume
| Issue : 6 | Page : 729-735
Clinical, biochemical & cytomorphologic study on Hashimoto's thyroiditis
Tina Thomas1, Suja Sreedharan1, Urmila N Khadilkar2, D Deviprasad1, M Panduranga Kamath1, Kiran M Bhojwani1, Arathi Alva1
1 Department of Otorhinolaryngology, Head & Neck Surgery, Kasturba Medical College, Manipal University, Mangalore, India
2 Department of Pathology, Kasturba Medical College, Manipal University, Mangalore, India
|Date of Submission||25-Apr-2013|
|Date of Web Publication||3-Mar-2015|
Professor & Head, Department of Otorhinolaryngology Head & Neck Surgery, Kasturba Medical College, Manipal University, Mangalore 575 001, Karnataka
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background & objectives: Despite, the extensive salt iodization programmes implemented in India, the prevalence of goiter has not reduced much in our country. The most frequent cause of hypothyroidism and goiter in iodine sufficient areas is Hashimoto's thyroiditis (HT). This study records the clinical presentation, biochemical status, ultrasonographic picture and cytological appearance of this disease in a coastal endemic zone for goiter.
Methods: Case records of patients with cytological diagnosis of HT were studied in detail, with reference to their symptoms, presence of goiter, thyroid function status, antibody levels and ultrasound picture. Detailed cytological study was conducted in selected patients.
Results: A total of 144 patients with cytological proven HT/lymphocytic thyroiditis were studied. Ninety per cent of the patients were females and most of them presented within five years of onset of symptoms. Sixty eight per cent patients had diffuse goiter, 69 per cent were clinically euthyroid and 46 per cent were biochemically mildly hypothyroid. Antibody levels were elevated in 92.3 per cent cases. In majority of patients the sonographic picture showed heterogeneous echotexture with increased vascularity. Cytological changes were characteristic.
Interpretation & conclusions: Our study showed predominance of females in the study population in 21-40 yr age group with diffuse goiter. We suggest that in an endemic zone for goiter, all women of the child bearing age should be screened for HT.
Keywords: Antithyroid antibody - cytology - FNA - goiter - Hashimoto′s thyroiditis - hypothyroidism - lymphocytic infiltration
|How to cite this article:|
Thomas T, Sreedharan S, Khadilkar UN, Deviprasad D, Kamath M P, Bhojwani KM, Alva A. Clinical, biochemical & cytomorphologic study on Hashimoto's thyroiditis. Indian J Med Res 2014;140:729-35
|How to cite this URL:|
Thomas T, Sreedharan S, Khadilkar UN, Deviprasad D, Kamath M P, Bhojwani KM, Alva A. Clinical, biochemical & cytomorphologic study on Hashimoto's thyroiditis. Indian J Med Res [serial online] 2014 [cited 2020 Apr 5];140:729-35. Available from: http://www.ijmr.org.in/text.asp?2014/140/6/729/152444
Endemic goiter is a major health problem in India. Widespread national salt iodization programmes implemented by the Government of India have not shown a dramatic decline in the prevalence of endemic goiter  . The reason for the high prevalence of goiter is not fully understood. A genetic predisposition of the Indian population for development of autoimmune goiter has been suggested  . Secondly, iodine itself could induce autoimmunity in patients. Iodine induced thyroiditis is well established in animal studies  . It has also been seen that iodine supplementation in iodine deficient areas increases the prevalence of lymphocytic infiltration of thyroid by three-fold; with 40 per cent increase in prevalence of antithyroid antibodies in serum over 0.5 to 5 years  .
This study was carried out at a tertiary care hospital located in the western coastal area known for endemicity of goiter, where sea food is the staple diet of the population. Moreover, there is a widespread use of iodized salt in the population. In spite of this, increasing numbers of goiters diagnosed to have Hashimoto's thyroiditis (HT) have been observed. We undertook this study to understand the clinical presentation, biochemical status and ultrasonographic picture of HT in this area. We also did a cytological analysis on a few patients to analyse the typical cytomorphologic features of HT and associated the clinical features, biochemical thyroid status and cytological parameters with each other to understand the pathogenesis of the disease.
| Materials & Methods|| |
This study was conducted in the department of Otorhinolaryngology, Head and Neck surgery, Kasturba Medical College, Mangalore, Karnataka, India, on 144 patients with HT. This was a cross-sectional study conducted on patients with cytologic diagnosis of Hashimoto's thyroiditis/lymphocytic thyroiditis (LT) during January 2001 to July 2011. Retrospective analysis of the medical records of patients was carried out from 2001 to 2009 and prospective study of patients was done from July 2009 to July 2011. Patients with cytology proven HT/LT with or without associated pathology were included in the study. Patients with cytology of multinodular or colloid goiter were excluded. The study protocol was approved by the ethics committee of the hospital. Informed written consent was obtained from patients of prospective study group.
Information on clinical presentation with emphasis on age, sex, presenting complaints, duration of complaint, clinical signs of hyperthyroidism or hypothyroidism, presence of goiter and tenderness was recorded. Investigations noted were thyroid function tests namely T3 (triiodothyronine) (normal values 0.6-2.02 IU/ml), T4 (thyroxine) (normal values 5.13-14.06 IU/ml), TSH (thyroid stimulating hormone) (normal values 0.27-5.5 IU/ml), FreeT4 (normal values 0.93-1.71 IU/ml). Antithyroid antibody levels namely anti thyroid peroxidase (anti TPO) (normal values <35 IU/ml) and antithyroglobulin (anti Tg) antibody levels (normal values <35 IU/ml) were documented. The thyroid function tests and antithyroid antibody levels were estimated in our hospital lab by ECLIA (Electro chemilumniscence immune assay) method. (Automated Roche Cobas e411 Analyser, Roche Diagnostics, USA).
Ultrasonographic reports were also evaluated. Volume of gland, echo texture, echogenicity and vascularity were recorded in all possible cases. Volume was calculated using the formula: length x width x thickness x 0.52 (correction factor) for each lobe. A volume of 18.6 ± 4.5 ml was considered to be normal  . Treatment modalities offered to patients were also evaluated. A detailed cytological study was done in selected 52 cases from fine needle aspiration (FNA) smears from the last two years (2009-2011). The main parameters studied were amount of lymphocytes, lymphocytic infiltration and destruction of follicular cells and Hurthle cell change.
Statistical analysis was done using SPSS 17.0 (Chicago: SPSS Inc). Chi-square test and ANOVA were used and p<0.05 was considered as significant. Biochemical values of thyroid function, ultrasound characteristics of HT, cytological parameters and antithyroid antibody levels were correlated with one another using the Karl Pearson's correlation coefficient.
| Results|| |
A total of 144 patients with cytology proven HT/LT were included in the study. Of these, 46 patients were included retrospectively, while the prospective group had 98 patients. These were 129 females and 15 males ([Table 1]) , which indicated a significantly higher percentage of females having HT as compared to males (p<0.001). The age of the patients ranged from 9 to 75 yr. Mean age was 34.18 ± 12.71 yr. Maximum number of cases were noted in the 3 rd decade (20-30 yr age group, n=46) followed by the 4 th decade (31-40 yr age group, n=40). Patients in the third decade were significantly more affected than those in other age groups (p<0.001).
|Table 1: Clinical findings in Hashimoto's thyroiditis in our study population (n=144) |
Click here to view
Ninety seven patients had documentation about the duration of their symptoms; 87 (89.6%) patients presented to hospital within 5 years of symptom manifestation ([Table 1]). t0 he difference was significant when compared with patients presenting at a later date (p<0.001).
Goiter was present in 100 cases, 14 cases were documented as absent goiter and no comment was documented in 30 cases. A significant number of patients had a goiter at presentation (p<0.001). o0 f these 100 cases, goiter was diffuse in 68 cases, multinodular in 28 cases and solitary nodule in four cases. Clinically majority (n=100) of patients had no features of hypothyroidism or hyperthyroidism, only 12 cases were identified to have hypothyroid features and 22 had hyperthyroid features ([Table 1]). This showed that a significant number of patients were clinically euthyroid (p<0.001). Vague symptoms like generalized fatigue and malaise were reported by some patients. Pain/tenderness of thyroid gland was present in seven cases among the total 144 cases.
Based on TSH levels, there were 64 cases of hypothyroidism, 46 cases of euthyroidism and 30 of hyperthyroidism. Information was incomplete in rest of the cases ([Table 2]). There was a significant difference in the thyroid function status of the patients (p<0.01). The hypothyroid patients were classified into mild, moderate and severe based on the TSH levels (mild 5.5 - 45.5, moderate 45.5 - 85.5, severe >85.5 IU/ml). Significant number of patients had mild hypothyroidism (p<0.01). T4 levels were normal in 32 cases (subclinical hypothyroidism) and low in 24 cases (overt hypothyroidism) ([Table 2]). Volume, echo texture, echogenicity and vascularity of the gland were also recorded ([Table 2]).
|Table 2: Biochemical and ultrasonographic investigations in Hashimoto's thyroiditis patients |
Click here to view
AntiTg antibody levels were available in 33 cases, 31 cases had high value. Anti TPO antibody levels were available in 52 cases, of whom 48 had high value indicating that a significant number of patients had high antithyroid antibody levels (p<0.001).
Of the 81 patients treated thyroxine supplementation was given to 63 patients, antithyroid drugs (neomercazole/carbimazole) to 19 and symptomatic treatment given to six patients (propranolol, alprazolam, paracetamol, diclofenac); 46 patients received no treatment and surgery was done in 17 cases. Among patients with cases with cytologic diagnosis of HT, nine were proven to be HT by histopathology also while two were shown to be multinodular goiter and colloid goiter. Among patients diagnosed as papillary carcinoma with LT, two cases underwent total thyroidectomy with neck dissection and one was treated with completion thyroidectomy after hemithyroidectomy. One patient of papillary carcinoma with LT was proven to be Hurthle cell adenoma with colloid adenomatous goiter with LT after histopathologic examination. Another patient of papillary carcinoma with LT also had a lymph node with adult T cell lymphoma.
The various aspects studied in cytology were cellularity of smear, presence of follicular cells, Hurthle cells, degree of lymphocytes, presence of lymphocytic infiltration and destruction of follicular cells, presence of giant cells, colloid and lymphoepithelial (L:E) ratio ([Table 3]). Cellularity of smears was assessed as good, adequate, low and poor. Lymphocytes seen in the smears were graded as sparse, mild, moderate, moderately dense or abundant ([Figure 1]). Hurthle cells were absent in some smears, seen as occasional cells or small groups, or seen in many large groups ([Figure 2]). Lymphocytic infiltration and destruction were graded as present or absent ([Figure 3]). Centroblasts were absent, occasional or many. Colloid was absent in most with only two slides showing small blobs. Lymphoepithelial ratio ranged from 1:1 to 30:1.
|Figure 1: Prominent lymphoplasmacytic infiltrate of thyroid (arrow) in Hashimoto's thyroiditis (May-Grunwald-Giemsa stain, x400).|
Click here to view
|Figure 2: Hashimoto's cell change of follicular cells of thyroid (arrow) in Hashimoto's thyroiditis (May-Grunwald-Giemsa stain, x400).|
Click here to view
|Figure 3: Follicular cell infiltration by lymphocytes of thyroid (arrow) in Hashimoto's thyroiditis (Papanicolaou stain, x400).|
Click here to view
The duration of symptoms was found to have a significant association with presence of goiter (p<0.05). t0 here was no significant association between thyroid status and echogenicity of thyroid gland, antithyroid antibody, and intensity of lymphocytes, Hurthle cells, lymphocytic infiltration and destruction of follicular cells.
| Discussion|| |
Most of our patients with HT belonged to the 21-40 yr age group. In a study from Puducherry, maximum patients with HT were in their 3 rd decade  . In another study from Chandigarh, majority of patients were in 3 rd and 4 th decades  . Unlike the Indian studies, studies from the w0 est reported Hashimoto's thyroiditis being diagnosed between the 4 th and 6 th decades of life  . Thyroid diseases are always reported to be higher in the female population. The reported female to male ratio in Hashimoto's thyroiditis ranges from 15:1 to 3:1 , . Our gender ratio falls in this range. Most of our patients (61%) presented with symptoms of one year duration. The association of goiter with duration of symptoms before presentation was significant. But the biochemical thyroid status when associated with the same variable was found to have no significance. This shows that in our population, goiter but not symptoms of altered thyroid hormone status is a reason for seeking medical care.
The high occurrence (61%) of diffuse goiter in our study was similar to previous studies from India. In the study from Chandigarh on cytology proven Hashimoto's thyroiditis  , 93 per cent of patients had goiter, of whom 90 per cent were diffuse and 3 per cent were nodular. Nodules are seen in early stages of disease when clinical and hormonal changes are not yet established  . A study from Malaysia has reported that Indians have increased prevalence of diffuse goiter while Chinese have more of nodular presentation  .
Most of our patients were hypothyroid (subclinical and overt), and of these only 38 per cent showed overt hypothyroidism. These results were similar to previous studies from India , and abroad  . In our study, 21 per cent patients had hyperthyroidism, not seen in other studies. i0 t is interesting to note that 66 per cent of the hyperthyroid patients presented in less than one year duration for evaluation.
We found 93 per cent of our patients were anti TPO positive and 92 per cent of them were anti Tg positive. There is a well-recognized discrepancy between antibody levels and cytology in Hashimoto's thyroiditis in children and young adults  . This could be because that in early stage of disease, antibody production is confined to intrathyroidal lymphocytes  . On the other hand, patients with significant titres may not have cytology proven Hashimoto's thyroiditis. This can be explained by the fact that focal LT which is an early lesion may be missed by cytology  .
Ultrasonography reports were studied in a limited number of cases. In our study, the volume of gland was enlarged in 41 per cent and normal in another 41 per cent of patients. Studies have shown that thyroid volume changes as the disease progresses from euthyroid to overtly hypothyroid with smaller volumes found in overt hypothyroidism  . Our study showed 64 per cent cases with normal thyroid echogenicity and 36 per cent cases with diffuse hypoechogenicity. Low echogenicity is due to altered thyroid structure because of disruption of follicles and diffuse lymphocytic infiltration  . Studies from India  and abroad  have shown 80-85 per cent of cases having normal echogenicity.
In fine needle aspiration cytology of thyroid, L:E ratio (lymphoid:epithelial ratio) in Hashimoto's thyroiditis ranges from 2:1 to 10:1  . We found moderate to abundant lymphocytic infiltrate in 69.3 per cent cases and lymphocytic infiltration of follicular cells in 57.7 per cent cases. An increase in number of epithelial cells raises suspicion of epithelial proliferative process associated with HT like malignancy  . Plasma cells were seen in 75 per cent of our cases. Plasma cells are useful in diagnosing early Hashimoto's thyroiditis where lymphocytic infiltration of follicles is insignificant  . a0 wide range of Hurthle cell change in Hashimoto's thyroiditis (48-98%) has been reported  . As seen in our study, absent or scanty colloid is a usual feature in Hashimoto's thyroiditis, but paradoxical presence of colloid , is not unusual due to a combination of iodine supplementation and autoimmunity  .
Our study showed no association between the thyroid status and antibody positivity, sonographic hypoechogenicity or cytologic parameters. Though many previous studies resemble ours ,, , a few studies have shown positive correlation of biochemical parameters with reduction in echogenicity in sonography , , lymphocytic infiltration , and antibody status  . A study with long term follow up has reported presence of raised TSH along with positive TPO antibodies which raises the risk of developing overt hypothyroidism  .
v0 arious neoplastic and non-neoplastic lesions are shown to be associated with HT on FNA like colloid goiter, cellular adenoma, follicular neoplasm, Hurthle cell neoplasm, papillary carcinoma, non-Hodgkins lymphoma (NHL) and follicular carcinoma  . Therefore four cases of malignancies associated with HT on cytology in our study group, three of whom were papillary carcinoma and one was medullary carcinoma.
The most commonly encountered neoplasms in association with HT are papillary thyroid carcinoma (PTC) and primary thyroid lymphoma. Several studies have attempted to define relationship between HT and PTC. In a population of patients with thyroid cancers, 1.9 times higher rate of HT were seen in patients with PTC, when compared with other cancers. On the other hand, there is a 2-3 times increased risk of development of PTC in presence of HT  . The presence of a dominant nodule, decreased response to suppressive therapy or clinical signs of metastasis should raise suspicion of PTC in patients with HT. FNA is useful in diagnosis of patients with HT associated lesions with a sensitivity of >90 per cent  . m0 any studies have been done on the prognosis of LT in PTC, majority of these reporting protective role of autoimmunity in terms of less aggressive disease at presentation, low recurrence  and improved survival  .
Our study had several limitations. The lack of complete data for all variables in all patients has reduced the sample size in the analysis of the various parameters. Antithyroid antibody levels were available only in a few patients, cost constraints being the main limiting factor. T3, T4, TSH and antibody levels at the time of presentation to hospital were taken.
In conclusion, Hashimoto's thyroiditis was diagnosed in goiter in our patients who came from the iodine sufficient western coastal belt. The presence of goiter and hypothyroidism points towards the necessity of further evaluation of disease. Ultrasound compliments diagnosis with its characteristic features but cytology is confirmatory. Association of HT with malignancy requires a close follow up of these patients.
| Acknowledgment|| |
The study was partially supported by the TMA Pai Research grant (Manipal University), Manipal, India.
| References|| |
Unnikrishnan AG, Menon UV. Thyroid disorders in India: an epidemiological perspective. Indian J Endocrinol Metab
(Suppl 2) : 78-81.
Jayaram G, Iyengar KR, Sthaneshwar P, Hayati JN. Hashimoto's thyroiditis - A Malaysian perspective. J Cytol
Sundick RS, Bagchi N, Brown TR. The role of iodine in thyroid autoimmunity: from chickens to humans: a review. Autoimmunity
Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med
Rumack CM, Wilson SR, Charboneau JW, editors. Diagnostic ultrasound
. 4 th
ed. St. Louis: Mosby; 1998.
Singh N, Kumar S, Negi VS, Siddaraju N. Cytomorphologic study of Hashimoto's thyroiditis and its serologic correlation: a study of 150 cases. Acta Cytol
Bhatia A, Rajwanshi A, Dash RJ, Mittal BR, Saxena AK. Lymphocytic thyroiditis - is cytological grading significant? A correlation of grades with clinical, biochemical, ultrasonographic and radionuclide parameters. Cyto Journal
: 10 .
Larson SD, Jackson LN, Riall TS, Uchida T, Thomas RP, Qiu S, et al
. Increased incidence of well-differentiated thyroid cancer associated with Hashimoto's thyroiditis and the role of the PI3k/Akt pathway. J Am Coll Surg
: 764-73; discussion 773-5.
Marwaha RK, Tandon N, Karak AK, Gupta N. Verma K, Kochupillai N. Hashimoto's thyroiditis: countrywide screening of goitrous healthy young girls in postiodization phase in India. J Clin Endocrinol Metab
Baker JR Jr, Saunders NB, Wartofsky L, Tseng YC, Burman KD. Seronegative Hashimoto thyroiditis with thyroid auto antibody production localized to the thyroid. Ann Intern Med
Nordmeyer JP, Shafeh TA, Heckmann C. Thyroid sonography in autoimmune thyroiditis.A prospective study on 123 patients. Acta Endocrinol (Copenh)
Marcocci C, Vitti P, Cetani F, Catalano F, Concetti R, Pinchera A. Thyroid ultrasonography helps to identify patients with diffuse lymphocytic thyroiditis who are prone to develop hypothyroidism. J Clin Endocrinol Metab
Marwaha RK, Sankar R, Magdum M, Nijahvan VS, Khanna CM, Jaggi CB, et al
. Clinical, biochemical and cytomorphological observations in juvenile chronic lymphocytic thyroiditis. Indian Pediatr
Kumar N, Ray C, Jain S. Aspiration cytology of Hashimoto's thyroiditis in an endemic area. Cytopathology
Poropatich C, Marcus D, Oertel YC. Hashimoto's thyroiditis: fine-needle aspirations of 50 asymptomatic cases. Diagn Cytopathol
Pandit AA, Vijay Warde M, Menon PS. Correlation of number of intrathyroid lymphocytes with antimicrosomal antibody titer in Hashimoto's thyroiditis. Diagn Cytopathol
Tunbridge WM, Brewis M, French JM, Appleton D, Bird T, Clark F, et al
. Natural history of autoimmune thyroiditis. Br Med J
(Clin Res Ed) 1981; 282
Singh B, Shaha AR, Trivedi H, Carew JF, Poluri A, Shah JP. Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome. Surgery
: 1070-6; discussion 1076-7.
Cunha LL, Ferreira RC, Marcello MA, Vassallo J, Ward LS. Clinical and pathological implications of concurrent autoimmune thyroid disorders and papillary thyroid cancer. J Thyroid Res
[Figure 1], [Figure 2], [Figure 3]
[Table 1], [Table 2], [Table 3]